We understand how structural changes are disrupting the sector — and creating opportunities for companies and investors. These include trends related to reimbursement models; consolidation, development, and commercialization of new technologies; accelerating consumerism; and the ever-evolving complexities of state and federal regulations. We are also at the forefront of issues arising from the convergence of traditional healthcare with innovative technologies, including those driven by artificial intelligence, machine learning, big data, and digital therapeutics.
To fuel growth across the business lifecycle, we connect healthcare innovators with our private equity and venture capital clients. That includes everything from health systems and physician practices to dental and hospice service providers. We also have a long record of successfully defending clients in FCA qui tam litigation and fraud and abuse investigations as well as on matters involving reimbursement disputes and disclosures to proactively mitigate risks.
Connect with our healthcare team and let us know how we can help.